BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32213121)

  • 1. A Modified MCT-Based Ketogenic Diet Increases Plasma β-Hydroxybutyrate but Has Less Effect on Fatigue and Quality of Life in People with Multiple Sclerosis Compared to a Modified Paleolithic Diet: A Waitlist-Controlled, Randomized Pilot Study.
    Lee JE; Titcomb TJ; Bisht B; Rubenstein LM; Louison R; Wahls TL
    J Am Coll Nutr; 2021 Jan; 40(1):13-25. PubMed ID: 32213121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trial.
    Wahls T; Scott MO; Alshare Z; Rubenstein L; Darling W; Carr L; Smith K; Chenard CA; LaRocca N; Snetselaar L
    Trials; 2018 Jun; 19(1):309. PubMed ID: 29866196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet-induced ketosis in adult patients with subacute acquired brain injury: a feasibility study.
    Edwards MGP; Andersen JR; Curtis DJ; Riberholt CG; Poulsen I
    Front Med (Lausanne); 2023; 10():1305888. PubMed ID: 38571572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Diet on Fatigue and Quality of Life in Multiple Sclerosis: A Systematic Review and Network Meta-analysis of Randomized Trials.
    Snetselaar LG; Cheek JJ; Fox SS; Healy HS; Schweizer ML; Bao W; Kamholz J; Titcomb TJ
    Neurology; 2023 Jan; 100(4):e357-e366. PubMed ID: 36257717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease.
    Phillips MCL; Deprez LM; Mortimer GMN; Murtagh DKJ; McCoy S; Mylchreest R; Gilbertson LJ; Clark KM; Simpson PV; McManus EJ; Oh JE; Yadavaraj S; King VM; Pillai A; Romero-Ferrando B; Brinkhuis M; Copeland BM; Samad S; Liao S; Schepel JAC
    Alzheimers Res Ther; 2021 Feb; 13(1):51. PubMed ID: 33622392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and metabolic outcomes of a well-formulated ketogenic diet as an adjuvant therapeutic intervention for women with stage IV metastatic breast cancer: The Keto-CARE trial.
    Buga A; Harper DG; Sapper TN; Hyde PN; Fell B; Dickerson R; Stoner JT; Kackley ML; Crabtree CD; Decker DD; Robinson BT; Krystal G; Binzel K; Lustberg MB; Volek JS
    PLoS One; 2024; 19(1):e0296523. PubMed ID: 38166036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum neurofilament light chain in relapsing multiple sclerosis patients on a ketogenic diet.
    Oh U; Woolbright E; Lehner-Gulotta D; Coleman R; Conaway M; Goldman MD; Brenton JN
    Mult Scler Relat Disord; 2023 May; 73():104670. PubMed ID: 36996634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study.
    Bahr LS; Bock M; Liebscher D; Bellmann-Strobl J; Franz L; Prüß A; Schumann D; Piper SK; Kessler CS; Steckhan N; Michalsen A; Paul F; Mähler A
    Trials; 2020 Jan; 21(1):3. PubMed ID: 31898518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eating Pattern and Nutritional Risks among People with Multiple Sclerosis Following a Modified Paleolithic Diet.
    Titcomb TJ; Bisht B; Moore DD; Chhonker YS; Murry DJ; Snetselaar LG; Wahls TL
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32575774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
    Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
    Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance, adherence, and acceptability of a ketogenic 2.5:1 ratio, nutritionally complete, medium chain triglyceride-containing liquid feed in children and adults with drug-resistant epilepsy following a ketogenic diet.
    Griffen C; Schoeler NE; Browne R; Cameron T; Kirkpatrick M; Thowfeek S; Munn J; Champion H; Mills N; Phillips S; Air L; Devlin A; Nicol C; Macfarlane S; Bittle V; Thomas P; Cooke L; Ackril J; Allford A; Appleyard V; Szwec C; Atwal K; Hubbard GP; Stratton RJ
    Epilepsia Open; 2024 Apr; 9(2):727-738. PubMed ID: 38411329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy.
    Law TH; Davies ES; Pan Y; Zanghi B; Want E; Volk HA
    Br J Nutr; 2015 Nov; 114(9):1438-47. PubMed ID: 26337751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-Hydroxybutyrate (BHB), Glucose, Insulin, Octanoate (C8), and Decanoate (C10) Responses to a Medium-Chain Triglyceride (MCT) Oil with and without Glucose: A Single-Center Study in Healthy Adults.
    Heidt C; Fobker M; Newport M; Feldmann R; Fischer T; Marquardt T
    Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in Micronutrient Intake among People with Relapsing-Remitting Multiple Sclerosis Adapting the Swank and Wahls Diets: An Analysis of Weighed Food Records.
    Titcomb TJ; Brooks L; Smith KL; Ten Eyck P; Rubenstein LM; Wahls TL; Snetselaar LG
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended Ketogenic Diet and Physical Training Intervention in Military Personnel.
    LaFountain RA; Miller VJ; Barnhart EC; Hyde PN; Crabtree CD; McSwiney FT; Beeler MK; Buga A; Sapper TN; Short JA; Bowling ML; Kraemer WJ; Simonetti OP; Maresh CM; Volek JS
    Mil Med; 2019 Oct; 184(9-10):e538-e547. PubMed ID: 30877806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-fat versus ketogenic diet in Parkinson's disease: A pilot randomized controlled trial.
    Phillips MCL; Murtagh DKJ; Gilbertson LJ; Asztely FJS; Lynch CDP
    Mov Disord; 2018 Aug; 33(8):1306-1314. PubMed ID: 30098269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a Paleo Ratio to Assess Adherence to Paleolithic Dietary Recommendations in a Randomized Controlled Trial of Individuals with Type 2 Diabetes.
    Mårtensson A; Stomby A; Tellström A; Ryberg M; Waling M; Otten J
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33802738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Medium Chain Triglycerides on Time to Nutritional Ketosis and Symptoms of Keto-Induction in Healthy Adults: A Randomised Controlled Clinical Trial.
    D C Harvey CJ; Schofield GM; Williden M; McQuillan JA
    J Nutr Metab; 2018; 2018():2630565. PubMed ID: 29951312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: estimated potential contribution to brain energy metabolism.
    Courchesne-Loyer A; Fortier M; Tremblay-Mercier J; Chouinard-Watkins R; Roy M; Nugent S; Castellano CA; Cunnane SC
    Nutrition; 2013 Apr; 29(4):635-40. PubMed ID: 23274095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Satiating Effect of a Ketogenic Diet and Its Impact on Muscle Improvement and Oxidation State in Multiple Sclerosis Patients.
    Benlloch M; López-Rodríguez MM; Cuerda-Ballester M; Drehmer E; Carrera S; Ceron JJ; Tvarijonaviciute A; Chirivella J; Fernández-García D; de la Rubia Ortí JE
    Nutrients; 2019 May; 11(5):. PubMed ID: 31126118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.